Toshifumi Yokota

University of Alberta — Canada

Biochemistry, Genetics and Molecular Biology · Life Sciences

44h-index5.6kcitations189works4.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Muscle Physiology and Disorders(119), Neurogenetic and Muscular Disorders Research(47), CRISPR and Genetic Engineering(42), RNA Interference and Gene Delivery(34), RNA Research and Splicing(23)

Publications189 total

Local Non-Coding Regulatory Elements in Muscular Dystrophies
International Journal of Molecular Sciences·2025Open Access
DG9-Conjugated Morpholino-Based Exon 51-Skipping Therapy for Duchenne Muscular Dystrophy
Methods in molecular biology·2025
DG9-Conjugated Morpholino Rescues Phenotype in Spinal Muscular Atrophy Mice
Methods in molecular biology·2025· 1 cited
Upgrading nucleic acid and antisense therapeutics: challenges, solutions, and future directions
Bioanalysis·2025
Local Non-Coding Regulatory Elements in the Muscular Dystrophies
Preprints.org·2025Open Access
Cardiac Cell and Animal Models for Duchenne Muscular Dystrophy in the Era of Gene Therapy and Precision Medicine
Preprints.org·2025Open Access
Brogidirsen and Exon 44 Skipping for Duchenne Muscular Dystrophy: Advances and Challenges in RNA-Based Therapy
Genes·2025· 1 citedOpen Access
Brogidirsen and Exon 44 Skipping for Duchenne Muscular Dystrophy: Advances and Challenges in RNA-Based Therapy
Preprints.org·2025Open Access
Gene Editing for Duchenne Muscular Dystrophy: From Experimental Models to Emerging Therapies
Degenerative Neurological and Neuromuscular Disease·2025· 7 citedOpen Access
AOC 1044 induces exon 44 skipping and restores dystrophin protein in preclinical models of Duchenne muscular dystrophy
Nucleic Acids Research·2025· 5 citedOpen Access
Analysis of Exon Skipping Applicability for Dysferlinopathies
Cells·2025· 1 citedOpen Access
Systemic Injection of Peptide-PMOs into Humanized DMD Mice and Detection by RT-PCR and ELISA
Methods in molecular biology·2025
In Vitro Evaluation of Antisense-Mediated Exon Inclusion for Spinal Muscular Atrophy
Methods in molecular biology·2025
Systemic Injection of Antisense Oligos into Spinal Muscular Atrophy (SMA) Mice and Evaluation
Methods in molecular biology·2025
Morpholino-Mediated Exon Skipping Targeting Human ACVR1/ALK2 for Fibrodysplasia Ossificans Progressiva
Methods in molecular biology·2025
Progress and Future Directions in Exon Skipping and Inclusion Therapies: The Landscape of Oligonucleotide-Based Genetic Medicine
Methods in molecular biology·2025· 1 cited
Creation of DMD Muscle Cell Model Using CRISPR-Cas9 Genome Editing to Test the Efficacy of Antisense-Mediated Exon Skipping
Methods in molecular biology·2025
Evolution and Breakthroughs in Exon Skipping and Splice Modulation: From Inception to Clinical Success
Methods in molecular biology·2025
Quantitative Evaluation of Exon Skipping in Immortalized Muscle Cells in Vitro
Methods in molecular biology·2025
In Vivo Evaluation of Multiple Exon Skipping with Peptide-PMOs in Cardiac and Skeletal Muscles in Dystrophic Dogs
Methods in molecular biology·2025
page 1 of 10Next →

Frequent Co-authors

Shin’ichi Takeda(13), Rika Maruyama(11), Yusuke Echigoya(11), Kenji Rowel Q. Lim(10), Akinori Nakamura(6), Quynh Nguyen(6), Terence A. Partridge(5), Yoshitsugu Aoki(4), Tejal Aslesh(4), Qilong Lu(3), Eric P. Hoffman(3), Merryl Rodrigues(3), So‐ichiro Fukada(3), T. Miyauchi(2), Katsutoshi Yuasa(2), Takaaki Ikemoto(2), Yuko Miyagoe‐Suzuki(2), Tetsuya Nagata(2), Hong M. Moulton(2), Terry Partridge(2)